111 Stock Price, News & Analysis

111, Inc. (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, has announced it will report its unaudited financial results for the third quarter ended September 30, 2024, before the U.S. market opens on Thursday, November 28, 2024. The company's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on the same day.

Participants are required to register in advance using the provided link. Upon registration, they will receive dial-in information, including a passcode and unique access PIN. A live and archived webcast of the conference call will be available on the company's website. Additionally, a telephone replay of the call will be accessible until December 5, 2024, with dial-in numbers provided for China, United States, and international callers.

111, Inc. (NASDAQ: YI) has expanded its national supply chain network with new fulfillment centers in Guangzhou and Wuhan. These additions bring the total number of centers to 13 across China, enhancing the company's warehousing and distribution capabilities. The new centers utilize an innovative operational model that reduces costs and improves efficiency, enabling 24-hour deliveries in most South and Central China markets.

The expansion strengthens 111's nationwide logistics network, 'Kunpeng,' which has reduced delivery costs by 15% and damage rates by 55%. The company's smart supply chain management systems, powered by over 30 self-developed technologies, support these operations. 111's virtual pharmacy network now serves approximately 470,000 pharmacies and partners with over 500 global pharmaceutical companies and 4,500 distributors.

111, Inc. (NASDAQ: YI), a tech-enabled healthcare platform company in China, has received a notification from Nasdaq on September 26, 2024. The notice states that for the last 30 consecutive business days, the closing bid price of the company's American depositary shares (ADSs) was below the minimum requirement of $1.00 per share, as per Nasdaq Listing Rule 5450(a)(1).

The company has been granted a 180-day compliance period, until March 24, 2025, to regain compliance. If the closing bid price of YI's ADSs reaches $1.00 or higher for at least ten consecutive business days during this period, Nasdaq will confirm compliance in writing. If YI fails to regain compliance by March 24, 2025, it may be eligible for an additional 180-day compliance period, subject to Nasdaq staff determination.

111, Inc. assures that its business operations are not affected by this notification and intends to monitor the closing bid price of its ADSs, taking reasonable measures to regain compliance with Nasdaq's minimum bid price requirement.

111, Inc. (NASDAQ: YI), a leading tech-enabled healthcare platform in China, announced that its co-founders, Dr. Gang Yu and Mr. Junling Liu, have begun purchasing company shares from their personal funds. The purchases will be made on the open market at prevailing prices. The co-founders currently own 42.7% of the company's total issued share capital.

111 reported strong financial performance in Q2 2024, achieving operational profitability for the second consecutive quarter. Income from operations reached RMB3.3 million (US$0.5 million), compared to a loss of RMB41.4 million in Q2 2023. Non-GAAP income from operations was RMB8.5 million (US$1.2 million). The company also reported positive operating cash flow.

Additionally, 111 acquired four new patents, bringing its total to 28, enhancing its competitive advantages in operational efficiency and supporting long-term growth prospects.

111, Inc. (NASDAQ: YI) announced its Q2 2024 financial results, highlighting maintained operational profitability for the second consecutive quarter. Key points include:

- Net revenues were RMB3.4 billion (US$471.2 million), down 1.5% YoY
- Income from operations was RMB3.3 million, compared to a loss of RMB41.4 million in Q2 2023
- Operating expenses decreased 18.1% YoY to RMB204.3 million
- Operating expenses as a percentage of net revenues decreased by 120 basis points to 6.0%
- Positive operating cash flow for two consecutive quarters
- Non-GAAP income from operations was RMB8.5 million

The company emphasized improved operational efficiency, strategic initiatives, and focus on digital capabilities to drive growth in the healthcare e-commerce sector.

111, Inc. (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, has announced its participation in a fireside chat with Water Tower Research on September 5, 2024, at 11:00 a.m. ET. The event will feature Junling Liu, Co-Founder, Chairman, and CEO of 111, discussing the company's Q2 2024 earnings, strategic plans for the second half of 2024, and recent technological innovations, including AI applications in its supply chain platform.

The fireside chat will be conducted by Robert Sassoon, senior research analyst at Water Tower Research. Interested parties can register for this listen-only event through the provided registration link. A replay of the discussion will be available on 111's investor relations website under the 'Events' section.

111, Inc. (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, has announced it will report its unaudited financial results for the second quarter ended June 30, 2024, before the U.S. market opens on Thursday, August 29, 2024. The company will host an earnings conference call at 7:30 AM U.S. Eastern Time on the same day.

Participants are required to register in advance using the provided link. Upon registration, they will receive dial-in details, passcode, and a unique access PIN. A live and archived webcast of the conference call will be available on the company's website. Additionally, a telephone replay of the call will be accessible until September 5, 2024.

111, Inc. (NASDAQ: YI), a tech-enabled healthcare platform company in China, has appointed Grant Thornton Zhitong Certified Public Accountants LLP as its new independent registered public accounting firm. This change, effective July 19, 2024, replaces Deloitte Touche Tohmatsu Certified Public Accountants LLP. The decision was made after careful evaluation and approved by 111's board of directors and audit committee.

Grant Thornton will audit and report on 111's consolidated financial statements for the year ending December 31, 2024, as well as assess the effectiveness of the company's internal control over financial reporting. This change in auditors represents a significant shift in 111's financial oversight and reporting processes.

111, Inc. (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, has announced its participation in a fireside chat with Water Tower Research on July 18, 2024, at 2:00 p.m. ET. The event will feature Junling Liu, Co-Founder, Chairman, and CEO of 111, who will discuss the company's:

• Business model
• Strategic goals
• Competitive landscape and advantages
• Growth drivers
• Market opportunities

The fireside chat is a listen-only event, and interested parties can register using the provided link. A replay will be available on 111's investor relations website under the 'Events' section.